Loading...
Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
OBJECTIVE: To investigate the efficacy and safety of belimumab, a human immunoglobulin monoclonal antibody against B lymphocyte stimulator, in a subset of patients with systemic lupus erythematosus (SLE) who were hypocomplementemic (C3 <90 mg/dl and/or C4 <10 mg/dl) and anti–double‐stranded DN...
Na minha lista:
| Udgivet i: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6099508/ https://ncbi.nlm.nih.gov/pubmed/29671280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40511 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|